Middle East respiratory syndrome coronavirus: Difference between revisions
(Created page with "==Background== *New coronavirus was first described in September 2012, when it was reported to have caused fatal acute lower respiratory illness in a man in Saudi Arabia. *As o...") |
|||
| Line 3: | Line 3: | ||
acute lower respiratory illness in a man in Saudi Arabia. | acute lower respiratory illness in a man in Saudi Arabia. | ||
*As of May 16, 2013, no cases in the US | *As of May 16, 2013, no cases in the US | ||
==Diagnosis== | |||
#Immediately contact the Acute Communicable Disease Control Program (ACDC) at 213-240-7941, ask for the Administrator on Duty | |||
(AOD), if a patient meets the following criteria for MERS-CoV infection: | (AOD), if a patient meets the following criteria for MERS-CoV infection: | ||
#Suspicion of pulmonary parenchymal disease (e.g., pneumonia or acute respiratory distress syndrome based on clinical or radiological evidence of consolidation); AND | ##Suspicion of pulmonary parenchymal disease (e.g., pneumonia or acute respiratory distress syndrome based on clinical or radiological evidence of consolidation); AND | ||
#History of travel within the past 10 days to the Arabian Peninsula or neighboring countries | ##History of travel within the past 10 days to the Arabian Peninsula or neighboring countries | ||
(Bahrain, Iraq, Iran, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian territories, Qatar, Saudi | (Bahrain, Iraq, Iran, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian territories, Qatar, Saudi | ||
Arabia, Syria, the United Arab Emirates, and Yemen); AND | Arabia, Syria, the United Arab Emirates, and Yemen); AND | ||
# Illness is not already explained by any other infection or etiology, including all clinically indicated | ##Illness is not already explained by any other infection or etiology, including all clinically indicated | ||
tests for community-acquired pneumonia. | tests for community-acquired pneumonia. | ||
Revision as of 17:50, 19 May 2013
Background
- New coronavirus was first described in September 2012, when it was reported to have caused fatal
acute lower respiratory illness in a man in Saudi Arabia.
- As of May 16, 2013, no cases in the US
Diagnosis
- Immediately contact the Acute Communicable Disease Control Program (ACDC) at 213-240-7941, ask for the Administrator on Duty
(AOD), if a patient meets the following criteria for MERS-CoV infection:
- Suspicion of pulmonary parenchymal disease (e.g., pneumonia or acute respiratory distress syndrome based on clinical or radiological evidence of consolidation); AND
- History of travel within the past 10 days to the Arabian Peninsula or neighboring countries
(Bahrain, Iraq, Iran, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian territories, Qatar, Saudi Arabia, Syria, the United Arab Emirates, and Yemen); AND
- Illness is not already explained by any other infection or etiology, including all clinically indicated
tests for community-acquired pneumonia.
In addition, the following persons may be considered for evaluation for MERS-CoV infection:
- Persons who develop severe acute lower respiratory illness of known etiology within 10 days
after traveling from the Arabian Peninsula or neighboring countries but who do not respond to appropriate therapy; OR
- Persons who develop severe acute lower respiratory illness who are close contacts of a
symptomatic traveler who developed fever and acute respiratory illness within 10 days of traveling from the AP or neighboring countries.
See Also
The CDC guidance on MERS-CoV is available at [1]